Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.63 USD | -3.43% | +0.18% | -44.42% |
Business Summary
Number of employees: 265
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Genome Editing Technology
100.0
%
| 20 | 100.0 % | 78 | 100.0 % | +296.32% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 20 | 100.0 % | 78 | 100.0 % | +296.32% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gilmore O’Neill
CEO | Chief Executive Officer | 59 | 22-05-31 |
Erick Lucera
DFI | Director of Finance/CFO | 57 | 23-05-16 |
Linda Burkly
CTO | Chief Tech/Sci/R&D Officer | - | 23-07-23 |
Mei Baisong
CTO | Chief Tech/Sci/R&D Officer | 60 | 22-07-17 |
Chi Li
LAW | General Counsel | - | 21-06-13 |
Linea Aspesi
HRO | Human Resources Officer | - | 23-01-31 |
Charlene Stern
LAW | General Counsel | - | 12-12-31 |
Kate X. Zhang
PRN | Corporate Officer/Principal | - | 18-09-30 |
Caren Deardorf
PRN | Corporate Officer/Principal | 59 | 23-09-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Emma Reeve
CHM | Chairman | 63 | 21-09-02 |
David Scadden
BRD | Director/Board Member | 71 | 19-02-05 |
Akshay Vaishnaw
BRD | Director/Board Member | 61 | 16-07-27 |
Andrew Hirsch
BRD | Director/Board Member | 53 | 17-05-29 |
Jessica Hopfield
BRD | Director/Board Member | 59 | 18-02-15 |
Elliott Levy
BRD | Director/Board Member | 64 | 23-04-10 |
Director/Board Member | 65 | 21-10-25 | |
Gilmore O’Neill
CEO | Chief Executive Officer | 59 | 22-05-31 |
Meeta Chatterjee
BRD | Director/Board Member | 69 | 20-12-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 82,237,974 | 81,950,543 ( 99.65 %) | 0 | 99.65 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.42% | 463M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- EDIT Stock
- Company Editas Medicine, Inc.